Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06274632 · ClinicalTrials.gov registry record · NA

ADELANTE: A Randomized Controlled Trial to Improve Engagement in Care for Latinos With HIV

A NA study of HIV/AIDS, sponsored by Massachusetts General Hospital.

Recruiting
Registry status
NA
Development phase
250
Enrollment target
2
Study locations

NCT06274632: Recruiting NA study of HIV/AIDS, sponsored by Massachusetts General Hospital.

NCT06274632 is a NA study of HIV/AIDS that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 250 participants, below the 33,177-participant average among 61 other HIV/AIDS trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06274632, a NA study of HIV/AIDS, is actively recruiting participants, sponsored by Massachusetts General Hospital.

RECRUITING
Registry status
NA
Development phase
250 participants
Enrollment target
2
Study locations

Study Summary

The goal of this study is to test the effectiveness of ADELANTE on viral suppression among Latinos with HIV and viral non-suppression. Participants will receive ADELANTE (5-session, community health worker-delivered, problem-solving intervention) or enhanced care condition (ECC, 5 reminder phone calls). We will evaluate the overall effectiveness of ADELANTE compared with ECC on rates of viral suppression and emergency room visits and hospitalizations. Our hypothesis is that ADELANTE participants will achieve higher rates of viral suppression and will have lower rates of emergency room visits and hospitalizations compared with ECC at 12 months post-randomization.

Primary Outcome

Viral suppression is defined as number of participants with HIV RNA less than 200 cpm. Response determined by viral load values in the medical record closest to the scheduled 12-month date, allowing for a range of three months before or after the scheduled 12-month date.

Conditions Studied

Interventions

  • BEHAVIORAL ADELANTE

Study Locations (2)

Florida

  • University of Miami - Miami

Texas

  • Baylor College of Medicine - Houston

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2024-05-22
Est. Completion 2027-02-28
Phase NA
Massachusetts General Hospital

2,032 total trials

What NCT06274632 shows while recruiting

NCT06274632 is an interventional study that assigns participants to a tested intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, below the 33,177-participant average among 61 other HIV/AIDS trials with a reported enrollment target (99% lower).

The record links to 1 condition, with HIV/AIDS appearing as the primary indexed condition, and to 1 intervention - of which ADELANTE is the first listed.

NCT06274632 reports a single indexed study location in Florida, Texas.

Frequently Asked Questions

What is clinical trial NCT06274632 about?

NCT06274632 is a clinical study titled "ADELANTE: A Randomized Controlled Trial to Improve Engagement in Care for Latinos With HIV". The goal of this study is to test the effectiveness of ADELANTE on viral suppression among Latinos with HIV and viral non-suppression. Participants will receive ADELANTE (5-session, community health worker-delivered, problem-solving intervention) or enhanced care condition (ECC, 5 reminder phone cal...

What is the current status of trial NCT06274632?

This trial is currently recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2024-05-22. Estimated completion is 2027-02-28.

What conditions does trial NCT06274632 study?

This clinical trial studies the following conditions: HIV/AIDS.

What interventions are being tested in trial NCT06274632?

The interventions under investigation include: ADELANTE (BEHAVIORAL).

Who is sponsoring clinical trial NCT06274632?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06274632 being conducted?

This trial has 2 study locations across Florida, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV/AIDS

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06274632's enrollment target sits among peer trials

250 23rd of 61 higher than 39 of 61 other HIV/AIDS trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other HIV/AIDS trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00483249 · 250 participants · NA

    Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm

  • NCT00777712 · 250 participants

    Mechanisms Underlying Impaired Diabetic Wound Healing

  • NCT01451502 · 250 participants · NA

    Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units

  • NCT01771718 · 250 participants

    Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06274632, the US trial registry maintained by the National Library of Medicine. NCT06274632 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.